The indian pharma

  Kineret (anakinra) is a prescription medication used to treat certain autoimmune disorders, such as rheumatoid arthritis and neonatal-onset multisystem inflammatory disease (NOMID). It is given as a subcutaneous injection (injection under the skin) by a healthcare professional or self-administered by the patient. The recommended dosage of Kineret depends on the patient's body weight and medical history. The starting dose for rheumatoid arthritis is typically 100 mg per day, which may be increased to 200-300 mg per day if needed. The dosage for NOMID is determined based on the patient's age and weight. The dosage may be adjusted based on the patient's response to the medication and any side effects. Kineret works by blocking a protein called interleukin-1 (IL-1), which is involved in the immune response and inflammation. By blocking IL-1, Kineret can help to reduce inflammation and improve symptoms of autoimmune disorders. Common side effects of Kineret include injecti...

 Blincyto (blinatumomab) is a prescription medication used to treat certain types of acute lymphoblastic leukemia (ALL). It is given as an intravenous infusion (injection into a vein) by a healthcare professional. The recommended dosage of Blincyto depends on the patient's body weight and medical history. The starting dose is typically 9 mcg per day, which is gradually increased over the first few days of treatment to a maintenance dose of 28 mcg per day. The dosage may be adjusted based on the patient's response to the medication and any side effects. Blincyto works by attaching to two proteins called CD19 and CD3, which are found on the surface of certain types of leukemia cells and immune cells. By attaching to CD19 and CD3, Blincyto helps to activate the immune system and destroy the cancer cells. Common side effects of Blincyto include fever, chills, headache, nausea, fatigue, and infections. Blincyto can also cause serious side effects, such as cytokine release syndr...

  Monjuvi (tafasitamab) is a prescription medication used to treat certain types of B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL). It is given as an intravenous infusion (injection into a vein) by a healthcare professional. The recommended dosage of Monjuvi is 12 mg/kg of body weight administered on days 1, 4, 8, 15, and 22 of a 28-day treatment cycle for a total of 6 cycles. The dosage may be adjusted based on the patient's response to the medication and any side effects. Monjuvi works by attaching to a protein called CD19, which is found on the surface of certain types of B-cells, including those that make up DLBCL. By attaching to CD19, Monjuvi can help to destroy the cancer cells and slow down the growth of the tumor. Common side effects of Monjuvi include fatigue, diarrhea, fever, low white blood cell count, and infections. Monjuvi can also cause serious side effects, such as infusion-related reactions, low blood pressure, and severe infections. Patient...

 Trodelvy (sacituzumab govitecan) is a prescription medication used to treat metastatic triple-negative breast cancer (TNBC) and metastatic urothelial cancer. It is given as an intravenous infusion (injection into a vein) by a healthcare professional. The recommended dosage of Trodelvy is 10 mg/kg of body weight administered on days 1 and 8 of a 21-day treatment cycle until disease progression or unacceptable toxicity. The dosage may be adjusted based on the patient's response to the medication and any side effects. Trodelvy works by targeting a protein called Trop-2, which is overexpressed in certain types of cancer cells, including TNBC and urothelial cancer. By attaching to Trop-2, Trodelvy delivers a chemotherapy drug directly to the cancer cells, which can help to destroy the cancer cells and slow down the growth of the tumor. Common side effects of Trodelvy include nausea, diarrhea, fatigue, hair loss, decreased appetite, and low white blood cell count. Trodelvy can also...

 Retevmo (selpercatinib) is a prescription medication used to treat certain types of thyroid cancer and non-small cell lung cancer (NSCLC) that have specific genetic mutations. It is taken orally in the form of capsules. The recommended dosage of Retevmo depends on the patient's body weight and medical history. For the treatment of thyroid cancer, the recommended dose is 120 mg taken orally twice daily (total of 240 mg per day) with food. For the treatment of NSCLC, the recommended dose is 160 mg taken orally twice daily (total of 320 mg per day) with food. Retevmo works by blocking the activity of specific proteins that promote the growth and spread of cancer cells. By blocking the activity of these proteins, Retevmo can slow down or stop the growth of the cancer cells. Common side effects of Retevmo include diarrhea, nausea, vomiting, constipation, fatigue, and decreased appetite. Retevmo can also cause serious side effects, such as high blood pressure, liver problems, and ...

  Tukysa (tucatinib) is a prescription medication used to treat HER2-positive breast cancer. It is taken orally in the form of tablets. The recommended dosage of Tukysa is 300 mg taken orally twice daily (total of 600 mg per day) in combination with trastuzumab and capecitabine, two other medications used to treat breast cancer. Treatment with Tukysa may continue as long as the patient continues to benefit from it and does not experience unacceptable side effects. Tukysa works by inhibiting the growth of HER2-positive breast cancer cells. HER2 is a protein that promotes the growth and division of cancer cells. By blocking the activity of HER2, Tukysa can slow down or stop the growth of the cancer cells. Common side effects of Tukysa include diarrhea, nausea, vomiting, fatigue, and liver problems. Tukysa can also cause serious side effects, such as severe diarrhea, liver problems, and lung problems. Patients should inform their healthcare provider immediately if they experienc...

  Enhertu (trastuzumab deruxtecan) is a prescription medication used to treat HER2-positive breast cancer. It is given as an intravenous injection (IV) by a healthcare professional. The dosage of Enhertu depends on the patient's body weight and medical history. It is typically given at a dose of 5.4 mg/kg every three weeks, with a maximum dose of 900 mg per infusion. The duration of treatment varies depending on the response to the medication and the severity of the disease. Enhertu works by attaching to HER2-positive cancer cells, which are cells that have too much of a protein called human epidermal growth factor receptor 2 (HER2) on their surface. This attachment helps to destroy the cancer cells and slow down the growth of the tumor . Common side effects of Enhertu include nausea, fatigue, vomiting, decreased appetite, hair loss, and constipation. Enhertu can also cause serious side effects, such as lung problems, heart problems, and infusion-related reactions. Patients sh...

  Stelara (ustekinumab) is a prescription medication that is used to treat a variety of inflammatory conditions, including psoriasis, psoriatic arthritis, and Crohn's disease. It is given as an injection and works by targeting certain proteins in the body that contribute to inflammation. Stelara is administered as an injection under the skin (subcutaneous injection) or as an intravenous infusion (injection into a vein) by a healthcare professional. The dosage and frequency of the injection depends on the specific condition being treated and other factors such as the patient's weight and medical history. Common side effects of Stelara include headache, fatigue, nausea, and upper respiratory tract infections. Serious side effects can occur, such as serious allergic reactions or infections, including tuberculosis (TB), bacterial, viral, and fungal infections, which can be life-threatening. Stelara should not be used in people with a known hypersensitivity to ustekinumab or an...

Retevmo (selpercatinib) is a medication used in the treatment of several types of cancer, including non-small cell lung cancer (NSCLC) and thyroid cancer. Retevmo works by blocking certain proteins that contribute to the growth and spread of cancer cells. Some of the common side effects of Retevmo may include: 1. Diarrhea 2. Nausea and vomiting 3. Constipation 4. Abdominal pain 5. Dry mouth 6. Loss of appetite 7. Fatigue 8. Increased blood pressure 9. Headache 10. Weight gain More serious side effects may include: 1. Severe allergic reactions, such as hives, difficulty breathing, and swelling of the face, lips, tongue, or throat 2. Changes in heart rhythm or function, which can lead to heart failure or cardiac arrest 3. Liver problems, such as elevated liver enzymes, liver failure, or hepatitis 4. Lung problems, such as pneumonitis or interstitial lung disease 5. Increased risk of bleeding, such as from the gastrointestinal tract or brain It is important to discuss any potential sid...

  Tukysa (tucatinib) is a medication used in the treatment of HER2-positive breast cancer, which is a type of cancer that overexpresses the HER2 protein. Tukysa works by blocking the activity of HER2 protein, thereby preventing the growth and spread of cancer cells. Tukysa is available as an oral tablet, usually taken twice daily in combination with other medications, including trastuzumab and capecitabine. The specific dosage and duration of treatment may vary depending on the patient's individual factors, including their weight, overall health, and response to treatment. Like all medications, Tukysa can have potential side effects. Some of the more common ones include diarrhea, nausea, fatigue, and vomiting. More serious side effects may include liver problems, lung problems, and an increased risk of infections. It is important to discuss any potential side effects or concerns with your healthcare provider before starting treatment with Tukysa . As for the cost of Tukysa , thi...

  Enhertu (trastuzumab deruxtecan) is a medication used to treat HER2-positive breast cancer, which is a type of cancer that overexpresses the HER2 protein. It works by delivering a chemotherapy drug directly to the HER2-positive cancer cells, causing them to die. Enhertu is typically administered as an intravenous (IV) infusion over a period of several hours. The recommended dose of Enhertu is 5.4 mg/kg (up to a maximum of 600 mg) every three weeks, but the actual dosage and treatment duration may vary depending on the patient's individual factors, including their weight, overall health, and response to treatment. Like all medications, Enhertu can have potential side effects. Some of the more common ones include nausea, vomiting, diarrhea, and fatigue. More serious side effects may include heart problems, lung problems, and blood disorders. It is important to discuss any potential side effects or concerns with your healthcare provider before starting treatment with Enhertu . A...

  Stelara (ustekinumab) is a medication used to treat several autoimmune diseases, including psoriasis, psoriatic arthritis, and Crohn's disease. It works by blocking the activity of certain proteins in the body that contribute to inflammation and immune system dysfunction. Side Effects: Common side effects of Stelara include injection site reactions, headache, fatigue, and upper respiratory infections. More serious side effects may include an increased risk of infection, allergic reactions, and an increased risk of certain types of cancer. Dosage: The dosage of Stelara may vary depending on the specific condition being treated and the patient's weight. It is typically administered as an intravenous (IV) infusion or a subcutaneous injection. The initial dose is usually higher, followed by maintenance doses at regular intervals. Cost: The cost of Stelara can vary depending on several factors, including the dosage, the frequency of treatment, and the patient's insurance cove...

Xeljanz (Tofacitinib)- An Overview: Xeljanz contains active salt tofacitinib. It was the first FDA-approved tablet of its kind (JAK inhibitor). The medicine has been prescribed for beyond 9 years, since initial approval in 2012, for treating moderate to severe rheumatoid arthritis (RA). Xeljanz (tofacitinib) was approved for the treatment of adults with active psoriatic arthritis in 2017, adults with moderate to severe ulcerative colitis in 2018, and adults with active ankylosing spondylitis in 2021. In 2020, the medicine was approved for the treatment of children ages 2 years and older with active polyarticular course juvenile idiopathic arthritis. Tofacitinib Uses, Side Effects & Warnings Xeljanz (Tofacitinib) Uses: Xeljanz is a pill approved for the treatment of adults when a TNF inhibitor did not work well or could not be tolerated with: Moderate to Severe Rheumatoid Arthritis Moderate to Severe Ulcerative Colitis Active Psoriatic Arthritis Active Ankylosing Spondylitis Xelja...

  Carfilzomib 60 mg injection is a medication used in the treatment of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. It works by blocking certain enzymes in the body that contribute to the growth and spread of cancer cells. Carfilzomib is typically given as an intravenous (IV) injection or infusion over a period of several minutes. The specific dosing and duration of treatment may vary depending on the patient's response to treatment and any potential side effects that may occur. Like all medications, carfilzomib can have potential side effects. Some of the more common ones include fatigue, nausea, diarrhea, and low blood cell counts. More serious side effects may include heart problems, lung problems, and blood clots. It is important to discuss any potential side effects or concerns with your healthcare provider before starting treatment with carfilzomib . Carfilzomib is typically administered by a healthcare professional in a hospital or cli...

  Lynparza (olaparib) is a medication used to treat certain types of cancer, including ovarian cancer, breast cancer, and pancreatic cancer. It works by blocking an enzyme called PARP, which helps cancer cells repair damaged DNA. Lynparza is typically taken orally, in capsule form, twice daily. The specific dosing and treatment regimen may vary depending on the type and stage of cancer being treated, as well as other individual factors such as weight and overall health. Like all medications, Lynparza can have potential side effects. Some of the more common ones include nausea, vomiting, fatigue, and anemia. More serious side effects may include an increased risk of infection, lung problems, and bone marrow suppression. It is important to discuss any potential side effects or concerns with your healthcare provider before starting treatment with Lynparza. Lynparza is a targeted therapy that is designed to work specifically against cancer cells with certain genetic mutations. It is ...

 Arsenic trioxide injection is a medication used in the treatment of a type of leukemia called acute promyelocytic leukemia (APL). It works by promoting the maturation and death of cancer cells. The recommended dose of arsenic trioxide injection for APL is based on the patient's weight and is typically given as a slow intravenous infusion over a period of 2 hours. Treatment usually consists of an initial induction phase followed by a maintenance phase. Like all medications, arsenic trioxide injection can have potential side effects. Some of the more common ones include nausea, vomiting, diarrhea, fatigue, and fever. More serious side effects may include heart rhythm problems, liver toxicity, and nerve damage. It is important to discuss any potential side effects or concerns with your healthcare provider before starting treatment with arsenic trioxide injection. Close monitoring is typically required during treatment to detect and manage any side effects that may occur.

  Tofacitinib is a medication used to treat certain autoimmune conditions, such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by blocking certain enzymes in the body that contribute to inflammation. The standard recommended dose of tofacitinib for most adults is 5 mg taken orally twice daily. It is important to take this medication exactly as prescribed by your healthcare provider, and to follow any instructions for monitoring your condition while taking it. Like all medications, tofacitinib can have potential side effects. Some of the more common ones include headache, diarrhea, nausea, and upper respiratory infections. It is important to discuss any potential side effects or concerns with your healthcare provider before starting treatment with tofacitinib .

  Pomalidomide is a medication used to treat multiple myeloma, a type of cancer that affects the plasma cells in the bone marrow. It is available in capsule form in several strengths, including 4mg. The cost of Pomalidomide can vary depending on several factors, including the country or region where it is being sold, the manufacturer, and the specific pharmacy or hospital where it is being purchased. In the United States, for example, the cost of Pomalidomide 4mg capsules can range from around $20,000 to $30,000 per month, depending on the patient's insurance coverage and other factors. However, many patients may be eligible for financial assistance or discounts through the drug manufacturer or other programs. In other countries, the cost of Pomalidomide may be lower or higher, depending on local regulations, pricing policies, and availability. It is important to note that the cost of Pomalidomide may be covered by health insurance, including Medicare and Medicaid, depending o...

  Apalutamide is a medication used in the treatment of prostate cancer, specifically non-metastatic castration-resistant prostate cancer (NM-CRPC). It is available in tablet form in several strengths, including 60mg. The cost of Apalutamide can vary depending on several factors, including the country or region where it is being sold, the manufacturer, and the specific pharmacy or hospital where it is being purchased. In the United States, for example, the cost of Apalutamide 60mg can range from around $12,000 to $15,000 per month, depending on the patient's insurance coverage and other factors. However, many patients may be eligible for financial assistance or discounts through the drug manufacturer or other programs. In other countries, the cost of Apalutamide may be lower or higher, depending on local regulations, pricing policies, and availability. It is important to note that the cost of Apalutamide may be covered by health insurance, including Medicare and Medicaid, depen...

  Bosutinib is a medication used to treat certain types of leukemia, specifically chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is available in several strengths, including 100mg, 400mg, and 500mg tablets. The cost of Bosutinib can vary depending on several factors, including the country or region where it is being sold, the manufacturer, and the specific pharmacy or hospital where it is being purchased. In the United States, for example, the cost of Bosutinib can range from around $11,000 to $13,000 per month for the 100mg and 400mg tablets, respectively. The 500mg strength may be slightly more expensive. However, many patients may be eligible for financial assistance or discounts through the drug manufacturer or other programs. In other countries, the cost of Bosutinib may be lower or higher, depending on local regulations, pricing policies, and availability. It is important to note that the cost of Bosutini...

  Palbociclib is the generic name for the medication sold under the brand name Ibrance . It is a medication used to treat certain types of breast cancer, and it works by inhibiting proteins called cyclin-dependent kinases, which help to regulate cell growth and division. The price of Ibrance or Palbociclib 125mg can vary depending on several factors, including the country or region where it is being sold, the manufacturer, and the specific pharmacy or hospital where it is being purchased. In the United States, for example, the cost of Ibrance can range from around $11,000 to $13,000 per month, depending on the dosage and the patient's insurance coverage. However, many patients may be eligible for financial assistance or discounts through the drug manufacturer or other programs. In other countries, the cost of Palbociclib or Ibrance may be lower or higher, depending on local regulations, pricing policies, and availability. It is important to note that the cost of Palbociclib or I...

  Globucel Injection is a medication used to treat certain types of cancer, including Hodgkin's lymphoma and non-Hodgkin's lymphoma. It contains the active ingredient, brentuximab vedotin, and is given as an intravenous infusion. The dose and cost of Globucel Injection can vary depending on several factors, including the patient's weight, the type and stage of cancer being treated, and the country or region where the medication is being administered. In general, the cost of Globucel Injection can be quite high. In the United States, for example, a single dose of the medication can cost several thousand dollars, and a full course of treatment may require multiple doses over several months. It is important to note that the cost of Globucel Injection may be covered by health insurance, including Medicare and Medicaid, depending on the patient's specific plan and the reason for the treatment. Patients should check with their healthcare provider and insurance company to det...

  Anti-thymocyte globulin (ATG) is a medication used to suppress the immune system and treat conditions such as aplastic anemia, graft-versus-host disease, and kidney transplant rejection. The cost of ATG injections can vary widely depending on the brand, the dosage, and the location where it is being administered. In the United States, the cost of ATG can range from around $800 to $2000 per vial, and a single treatment course may require multiple vials depending on the patient's weight and the condition being treated. This can make the total cost of treatment tens of thousands of dollars or more. It is important to note that the cost of ATG injections may be covered by health insurance, including Medicare and Medicaid, depending on the patient's specific plan and the reason for the treatment. Patients should check with their healthcare provider and insurance company to determine their coverage options and out-of-pocket costs. Additionally, some pharmaceutical companies off...

  Trientine hydrochloride is a medication used in the treatment of Wilson's disease, a genetic disorder in which copper builds up in the body. This medication is a chelating agent, which means it binds to copper in the body and helps to remove it through urine. Trientine hydrochloride is taken orally, usually three times a day, with or without food. The dosage is based on the patient's weight and the severity of their condition. It is important to take this medication exactly as prescribed and not to miss any doses. Common side effects of trientine hydrochloride may include nausea, vomiting, diarrhea, abdominal pain, loss of appetite, and skin rash. More serious side effects may include liver problems, allergic reactions, and bone marrow suppression. Trientine hydrochloride should not be taken by pregnant or breastfeeding women, and it should be used with caution in patients with kidney or liver problems. Patients should also avoid taking other medications, supplements, or an...

  Foscarnet- An Overview:  Foscarnet is authorized as an antiviral agent. The medicine shows activity against human herpesviruses and HIV. It is used for the treatment of eye complications caused by CMV in individuals with AIDS. The drug is also used for the treatment of a type of HSV that cannot be treated by another drug in individuals with a weak immune system. Foscarnet sodium is supplied under the brand name Foscavir, which is an organic analogue of inorganic pyrophosphate that blocks the imitation of herpesviruses in vitro including CMV and HSV types 1 and 2. This medicinal product exerts its antiviral action by a selective blockage at the pyrophosphate binding site on virus-specific DNA polymerases at concentrations that do not impact cellular DNA polymerases. Foscarnet does not need activation by thymidine kinase or other kinases and therefore is enabled in vitro against HSV TK deficient mutants and CMV UL97 mutants. Thus, CMV strains resistant to ganciclovir or HSV s...